Journal of Clinical Psychopharmacology

Article	Citations
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)	49
Risperidone-Associated Stuttering in Patient With Schizophrenia	44
Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation	39
Blonanserin-Associated Leukopenia	38
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset	33
Pharmacogenetic Variant Related Higher-Than-Expected Clozapine Concentrations and Clozapine/Norclozapine Ratios in a Patient With Treatment-Resistant Schizoaffective Disorder	30
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic	27
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents	24
Concomitant Use of Clozapine and Suvorexant Doubled Clozapine Plasma Levels: A Case Report	17
Serum Transaminase Monitoring and Successful Treatment of ADHD With Dextroamphetamine in a Patient With Progressive Familial Intrahepatic Cholestasis Type 3	17
Hypersensitivity to Psychotropic Medications in a Patient With 17q12 Microdeletion Syndrome	17
Question	16
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series	16
Postinjection Syndrome After Paliperidone?	16
Clozapine Use for Bipolar Disorder	15
A Study of Cardiac Outcomes After Droperidol Administration in an Inpatient Psychiatric Cohort	14
Amisulpride-Associated QTc Prolongation	14
Recurrent Clozapine-Associated Pneumonia	13
Lethal Suicide Attempt After Dextromethorphan-Associated Sleep Terror	13
Notice of Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study	13
Question	13
Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment	12
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	12
Paliperidone and Edema	11
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder	11

The Yale University Open Data Access Project	11
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress	10
Treating Depression Following Biliopancreatic Diversion With Duodenal Switch Surgery	10
Use of Blonanserin Transdermal Patch in Home Treatment of Schizophrenia	10
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes	10
Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia	10
The Role of Case Series and Case Reports in Evidence-Based Medicine	9
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder	9
Monoamine Oxidase Interactions. Reply to Comments by Drs. Van den Eynde and Gillman	9
Subject Index 2023	9
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	9
Standard Binge Eating Treatments Are Not Effective for My Patient	8
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders	8
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition	8
Monoamine Oxidase Inhibitor Interactions	8
Methamphetamine-Associated Hyperammonemic Encephalopathy	8
Quetiapine in the Anxiety Dimension of Mood Disorders	8
Reply: Serotonin Paradox in Burning Mouth Syndrome	8
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum	8
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics	8
Predicting Conversion to Insulin Sensitivity With Metformin	8
Donepezil and Inappropriate Sexual Behavior in a Patient With Vascular Dementia and on Bupropion	8
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia	8
Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression	8
Ultra-Treatment–Resistant Schizophrenia and Clozapine Augmentation	7
How Homogeneous Are Diagnostic Groups?	7
Author Index 2022	7
Safe and Efficacious Use of Duloxetine in a Patient With Congenital Prolonged QT Syndrome	7
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates	7
Dysphagia to Liquids Only Associated With Olanzapine	7
Advancing the Development of New Medications to Treat Psychiatric Illness	7
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms	7
Can Quetiapine Prolong the Antidepressant Effect of Ketamine?	7
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman	7
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	7
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight	6
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia	6
Trazodone and Mianserin for Delirium	6
Mania in a Patient With Pituitrin-Associated Hyponatremia	6
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users	6
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India	6
Recurrent Pancreatitis Associated With Atomoxetine Use in a 9-Year-Old Boy	6
The Journal of Clinical Psychopharmacology Consent Policy for Case Reports	6
Esketamine for Unipolar Major Depression With Psychotic Features	5
Subject Index 2024	5
Effects of Clozapine on Cortical Inhibition	5
Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder	5
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases	5
The Impact of Serotonin Transporter Binding Affinity on the Risk of Bleeding Related to Antidepressants	5
New-Onset Sleepwalking in a Patient Treated With Buspirone	5

Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report	5
Central Nervous System Trial Failures	5
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	5
Treating Attention-Deficit/Hyperactivity Disorder in Severe Intellectual Disability with Lisdexamfetamine	5
A Seizure After COVID-19 Vaccination in a Patient on Clozapine	5
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use	5
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation	5
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma	5
Prevalence and Appropriateness of Antipsychotic Prescribing in an Italian Prison	5
Reply to Dr Yucel's Comments on the Article “Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression	4
Further Studies of Effects of Finasteride on Mood and Suicidal Risk	4
Alpha Lipoic Acid for Schizophrenia: Future Investigations With Low Doses and Treatment-Resistant Patients—Reply to Letter by Kishi and Colleagues	4
Cervical Dystonia in a Geriatric Patient Associated With Cinacalcet-Clozapine Drug Interaction	4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation	4
Current Status and Treatment of Rapid Cycling Bipolar Disorder	4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia	4
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	4
Challenges in the Treatment of Psychotic Bipolar Depression	4
Possibly Misleading Pharmaceutical Advertising On TV	4
Vortioxetine	4
A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder	4
Thoughts on the Value of Case Series in the Literature	4
Efficacy of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations	4
Structured Interventions to Optimize Polypharmacy in Psychiatric Treatment and Nursing Homes	4
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?	4
Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders	4
An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression	4
The Modernization of Clozapine	4
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder	4
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment	4
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease	4
Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up	4
Treatment of Clozapine-Associated Sialorrhea	4
Pharmacoepidemiology and Clinical Correlates of Lithium Treatment for Bipolar Disorder in Asia	4
Cerebellar Cognitive Affective Syndrome and Delusional Disorder Associated With Long-Term Phenytoin Use	4
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine	4
Are the Same Medications that Are Used in the Acute Treatment of Depression the Most Suitable for Preventing Relapse?	4
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia	4
Association of Optimal Lamotrigine Serum Levels and Therapeutic Efficacy in Mood Disorders	4
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19	4
Fluoxetine-Associated Enuresis in a Pediatric Patient	4
Asthma and Atypical Antipsychotics	4
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?	4
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients	4
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia	3
Quality Assurance of Depression Ratings in Psychiatric Clinical Trials	3
In Memoriam	3
Esketamine	3
Perphenazine-Associated Nausea	3
Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation	3
Albuterol-Associated Hallucinations	3
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly	3
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux	3
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine	3
Expanding Insights on Clozapine Dosing	3
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series	3
Characterization of Extended-Release Lorazepam	3
The Pitfalls of Psychotropic Polypharmacy	3
Treatment of Long-COVID Neuropsychiatric Sequelae Using Tricyclic Antidepressants	3
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users	3
Treatment History Characteristics Associated With Use of Isocarboxazid	3
Time for Rational Pharmacotherapy in Delusional Disorder	3
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine	3
Response to Letter to the Editors From Prof D. Taylor	3
Risperidone-Associated Acute Laryngeal Dystonia	3
Paroxysmal Perceptual Alterations in Response to Flupentixol	3
Adverse Effects After Ayahuasca Administration in the Clinical Setting	3
Article Selected to Receive the Mitchell B. Balter Award for 2022	3
Statistical Versus Clinical Significance	3
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning	3
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders	3
Case Report	3
Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials	3
Alprazolam	3
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder	3
The Need for Non-profit Psychiatric Drug Discovery and Development	3
Salute to Our Reviewers	3
Drug-Associated Liver Injury Related to Antipsychotics	3
Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole	3

Atomoxetine-Associated Possible Abnormal Uterine Bleeding in an Adolescent	3
Augmentation With Pimavanserin in Treatment Refractory Schizophrenia	3
Unfair Criticisms of Psychopharmacology	3